Deshaies Robert Joseph sold $174K of WEX

Deshaies Robert Joseph (COO, Benefits) sold 1,200 shares of WEX Inc. (WEX) at $144.84 ($0.17M total) on 2026-05-28.

Original reporting
SEC EDGAR · Deshaies Robert Joseph
Published Jun 1, 2026, 10:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 1, 2026, 11:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$WEX
Neutral
medium confidence
Mentioned
$WEX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WEXNeutralLow
01

Why it matters

This provides incremental sentiment information but no direct new information about WEX’s business, guidance, or financial results.

02

Market read

Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to drive a major repricing.

03

What to watch

Single-trade context (size vs. total holdings) and whether other insiders/funds are buying or selling can matter more than one officer’s sale.

Relevance 6/10Novelty 6/10Timing: After the SEC Form 4 filing (filed 2026-06-01 18:57 ET) for a sale dated 2026-05-28.

Background

The article is an SEC EDGAR Form 4 disclosure of an insider’s open-market sale by WEX COO (Benefits).

Company-level read

Ticker impact

$WEXNeutralMedium confidence
Context

WEX COO Deshaies sold 1,200 shares in an open-market transaction disclosed on SEC Form 4.

Expected impact

Low likelihood of a sustained price move solely from this disclosure; any reaction is likely limited and short-lived.

Evidence & confidence

The filing provides a single officer sale with no stated reason, no 10b5-1 plan, and no accompanying operational/financial news.

Market effects

Minimal—this is company-specific insider activity with no sector-wide regulatory or earnings signal.

None indicated.

None indicated.

Counterpoint

Because the sale is not explicitly tied to performance and could be diversification, the market may overreact to the absence of a 10b5-1 plan.

Key entities

  • WEX Inc.

    Subject of the insider transaction disclosure; COO (Benefits) sold shares.

  • Robert Joseph Deshaies

    WEX COO (Benefits) who executed the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WEXMed

WEX Extends Credit Facilities to 2031, Boosting Revolver to $1.7 Billion

WEX amended its credit agreement, extending the maturity of its revolving credit facility and tranche A term loans to 2031. The revolving commitments increased to $1.7 billion, and the tranche A term loan facility to $900 million. The amendment also repriced interest margins based on the company's leverage ratio, enhancing WEX's financing flexibility and liquidity.

$WEXHighAI 8/10

WEX Q3 2026 presentation: strong beat, raised guidance, stock slips

WEX Inc. reported Q3 2026 revenue of $780.1M and adjusted EPS of $6.13, beating estimates. Despite raising full-year guidance, shares fell 1.56%. Growth was partly driven by fuel prices and FX, with organic revenue up 4.4%. Mobility segment led growth, while Corporate Payments faced headwinds. The company maintained strong cash flow and repurchased $200M in shares.

$WEXMedAI 8/10

WEX Q3 Earnings Call Highlights

WEX reported Q3 adjusted operating margin expansion of 310 basis points, driven by higher fuel prices. Mobility revenue grew 20.6%, with organic growth accelerating to 4.4%. The company raised its full-year Mobility organic revenue growth forecast to 3%-5%. Benefits revenue rose 4.8% to $207.6M, while Corporate Payments revenue increased 3.5% to $137.4M. WEX updated its Q4 and full-year outlooks, expecting 5% organic revenue growth and 18% EPS growth excluding macro factors.

$WEXMed

WEX Inc (WEX) (Q3 2026) Earnings Call Highlights: Record Revenue

WEX Inc (WEX) reported Q3 2026 earnings with record revenue but lowered full-year Corporate Payments growth guidance to 4%-6% due to Middle East travel disruptions and delayed embedded payments. Benefits segment SaaS account growth slowed to 2.8%, and Mobility volumes were softer due to high diesel prices. Interest rates dragged on Benefits revenue, and Q4 credit losses are expected to rise.

$WEXHighAI 8/10

WEX (WEX) Q3 2026 Earnings Call Transcript

WEX reported Q3 2026 earnings with record revenue of $780.1M (+12.8% YoY) and adjusted EPS of $6.13 (+33.6% YoY). Organic growth was 4.4%, with AI initiatives and higher fuel prices contributing to performance. The company repurchased $200M in shares, reflecting strong cash generation. WEX highlighted progress in mobility, benefits, and corporate payments segments, emphasizing AI-driven innovations and strategic investments.